Platinum-Based Drug clinical trials

Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

This study is looking at new drug combinations for metastatic lung cancer. It combines durvalumab and tremelimumab, which are treatments that help your body's immune system fight cancer, sometimes with standard chemotherapy. We want to see if these new combinations are more effective.